108 related articles for article (PubMed ID: 8536137)
1. Epidemiological characteristics of prostate cancer in Gunma Prefecture, Japan. Gunma University Urological Oncology Study Group.
Nakata S; Sato J; Imai K; Yamanaka H; Ichinose Y
Int J Urol; 1995 Jul; 2(3):191-7. PubMed ID: 8536137
[TBL] [Abstract][Full Text] [Related]
2. [Chronological changes of incidence rates, clinical stages and pathological differentiation of prostate cancer in Gunma Prefecture, Japan].
Nakata S; Ohtake N; Kubota Y; Ito K; Suzuki K; Yamanaka H;
Hinyokika Kiyo; 2004 Mar; 50(3):165-70. PubMed ID: 15148767
[TBL] [Abstract][Full Text] [Related]
3. [An epidemiological study of urogenital cancer in Gunma Prefecture].
Nakata S; Kurita M; Imai K; Yamanaka H; Sato J; Kobayashi M; Tsuchiya K; Ichinose Y; Matsumoto K; Aikawa A
Nihon Hinyokika Gakkai Zasshi; 1994 Dec; 85(12):1734-42. PubMed ID: 7869647
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of prostate cancer in Gunma prefecture.
Kurokawa K; Fukabori Y; Ito K; Suzuki K; Nakata S; Suzuki T; Imai K; Namiki TS; Yamanaka H
Int J Androl; 2000; 23 Suppl 2():40-2. PubMed ID: 10849492
[TBL] [Abstract][Full Text] [Related]
5. Incidence of urogenital cancers in Gunma Prefecture, Japan: a 10-year summary.
Nakata S; Ohtake N; Kubota Y; Imai K; Yamanaka H; Ito Y; Hirayama N; Hasegawa K
Int J Urol; 1998 Jul; 5(4):364-9. PubMed ID: 9712446
[TBL] [Abstract][Full Text] [Related]
6. The correlation of stage and pathology of prostate cancer in Japan.
Kubota Y; Imai K; Yamanaka H
Int J Urol; 2000 Apr; 7(4):139-44. PubMed ID: 10810970
[TBL] [Abstract][Full Text] [Related]
7. [Chronological and regional differences of testicular cancer--epidemiological analysis of incidence in gunma prefecture and estimated data of national survey, and of death in Japan].
Nakata S; Takahashi H; Ohtake N; Yamanaka H
Nihon Hinyokika Gakkai Zasshi; 2002 Jan; 93(1):1-6. PubMed ID: 11842533
[TBL] [Abstract][Full Text] [Related]
8. Trends and characteristics in prostate cancer mortality in Japan.
Nakata S; Takahashi H; Ohtake N; Takei T; Yamanaka H
Int J Urol; 2000 Jul; 7(7):254-7. PubMed ID: 10910227
[TBL] [Abstract][Full Text] [Related]
9. Changes in baseline PSA levels in Japanese men from 1988 to 2003.
Ohi M; Ito K; Yamamoto T; Miyakubo M; Takechi H; Kubota Y; Suzuki K
Urology; 2008 Jul; 72(1):95-8. PubMed ID: 18455775
[TBL] [Abstract][Full Text] [Related]
10. A comparison of prostate cancer patients in Japan and the USA.
Imai K; Takahashi Y; Nakata S; Karr JP; Huben R
Int J Urol; 1994 Sep; 1(3):256-62. PubMed ID: 7614384
[TBL] [Abstract][Full Text] [Related]
11. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH
Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715
[TBL] [Abstract][Full Text] [Related]
12. [Prostate tumor and its diagnosis].
Yamanaka H
Rinsho Byori; 2001 Jul; 49(7):633-7. PubMed ID: 11519121
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of mass screening for the prognosis of prostate cancer patients in Japanese communities.
Kubota Y; Ito K; Imai K; Yamanaka H
Prostate; 2002 Mar; 50(4):262-9. PubMed ID: 11870805
[TBL] [Abstract][Full Text] [Related]
14. [The mass screening for prostate cancer and the age eligibility. Gunma Urological Oncology Study Group].
Imai K; Suzuki T; Kumasaka H; Kurosawa I; Kurihara J; Machida M; Makino T; Kiren H; Sato J; Yamanaka H
Nihon Hinyokika Gakkai Zasshi; 1996 Oct; 87(10):1191-6. PubMed ID: 8937115
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factor for prostate cancer. Gunma Urological Oncology Study Group].
Imai K; Suzuki T; Hayashi M; Nakazawa Y; Nakata S; Yamanaka H; Kitaura K; Tomaru Y; Miki M; Kato N
Nihon Hinyokika Gakkai Zasshi; 1990 Aug; 81(8):1217-24. PubMed ID: 2232414
[TBL] [Abstract][Full Text] [Related]
16. Trends in prostate cancer incidence, mortality and survival in England and Wales 1971-1998.
Majeed A; Babb P; Jones J; Quinn M
BJU Int; 2000 Jun; 85(9):1058-62. PubMed ID: 10848694
[TBL] [Abstract][Full Text] [Related]
17. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons.
Quinn M; Babb P
BJU Int; 2002 Jul; 90(2):162-73. PubMed ID: 12081758
[TBL] [Abstract][Full Text] [Related]
18. Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts.
Helgstrand JT; Røder MA; Klemann N; Toft BG; Lichtensztajn DY; Brooks JD; Brasso K; Vainer B; Iversen P
Cancer; 2018 Jul; 124(14):2931-2938. PubMed ID: 29723398
[TBL] [Abstract][Full Text] [Related]
19. [Statistical analysis of the prostatic cancer patients detected from 1985 to 1989 in and around Gunma prefecture].
Nakata S; Imai K; Uchida T; Yamanaka H; Hashimoto K; Ogura H; Nakano K; Kurita M; Saito Y; Ono Y
Hinyokika Kiyo; 1991 Oct; 37(10):1261-9; discussion 1269-70. PubMed ID: 1755419
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal trends in prostate cancer incidence, mortality, and survival of patients from two Shanghai city districts: a retrospective population-based cohort study, 2000-2009.
Hu Y; Zhao Q; Rao J; Deng H; Yuan H; Xu B
BMC Public Health; 2014 Apr; 14():356. PubMed ID: 24731197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
